Home/Filings/4/0001611286-25-000011
4//SEC Filing

Petersen Floyd F. 4

Accession 0001611286-25-000011

CIK 0001297184other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 5:17 PM ET

Size

6.5 KB

Accession

0001611286-25-000011

Insider Transaction Report

Form 4
Period: 2025-12-11
Transactions
  • Sale

    Common Stock

    2025-12-11$25.69/sh1,737$44,62073,794 total
  • Sale

    Common Stock

    2025-12-12$25.92/sh2,426$62,88871,368 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.9225 to $25.945, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Issuer

Amphastar Pharmaceuticals, Inc.

CIK 0001297184

Entity typeother

Related Parties

1
  • filerCIK 0001611286

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 5:17 PM ET
Size
6.5 KB